PUBLIC HEALTH: Synthetic biology's first malaria drug meets market resistance

    loading  Checking for direct PDF access through Ovid

Abstract

Commercial use of genetically engineered yeast to make medicine has modest impact.

Related Topics

    loading  Loading Related Articles